We are live on
!
Find out more
SCM
SG Capital Management Portfolio holdings
AUM
$1.21B
1-Year Est. Return
70.92%
This Fund
S&P 500
This Quarter
Est. Return
+33.06%
1 Year Est. Return
+70.92%
3 Year Est. Return
+250.18%
5 Year Est. Return
+487.12%
10 Year Est. Return
+4,831.3%
AUM
$1.21B
AUM Growth
-$294M
(-20%)
Cap. Flow
-$370M
Cap. Flow
% of AUM
-30.57%
Top 10 Holdings %
Top 10 Hldgs %
33.62%
Holding
125
New
37
Increased
12
Reduced
31
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$50.1M |
| 2 |
ESAB
ESAB
|
+$43.9M |
| 3 |
Silgan Holdings
SLGN
|
+$38.1M |
| 4 |
VSE Corp
VSEC
|
+$35.2M |
| 5 |
APi Group
APG
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$63.7M |
| 2 |
Watsco Inc
WSO
|
+$56.2M |
| 3 |
Onto Innovation
ONTO
|
+$54M |
| 4 |
Arrow Electronics
ARW
|
+$51.9M |
| 5 |
Jabil
JBL
|
+$49.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 43.31% |
| 2 | Technology | 23.31% |
| 3 | Consumer Discretionary | 10.04% |
| 4 | Miscellaneous | 9.5% |
| 5 | Healthcare | 6.85% |
Similar funds
NRG
CAS
MGCM
OCAM
SWGC
MNBTD
ELFC
SL
SG Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, SG Capital Management held 125 positions worth $1.21B, down 20% from $1.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
SG Capital Management withdrew a net $370M in Q2 2026, closing 45 positions and reducing 31 holdings. Its most notable exit was Bio-Techne, an estimated $63.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 43% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, SG Capital Management opened a new position in Zebra Technologies worth $56.1M.
- SG Capital Management's largest Q2 2026 buy was Zebra Technologies: 213,085 shares worth $56.1M.
- SG Capital Management added most to MSC Industrial Direct in Q2 2026, an estimated $27.2M increase.
- SG Capital Management's biggest Q2 2026 reduction was Watsco Inc, cutting an estimated $56.2M.
- SG Capital Management fully exited Bio-Techne in Q2 2026, selling an estimated $63.7M.
- SG Capital Management's ten largest holdings make up 34% of its $1.21B portfolio in Q2 2026.
- SG Capital Management opened 37 new positions and closed 45 in Q2 2026.
- SG Capital Management's portfolio value fell 20% quarter-over-quarter to $1.21B.
Based on SG Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.